Scientists hunt superbug in water and people to stop its spread
NCT ID NCT05282082
First seen Mar 11, 2026 · Last updated Jun 19, 2026 · Updated 12 times
Summary
This study aimed to create a smart surveillance strategy for carbapenem-resistant Pseudomonas aeruginosa (CRPA), a superbug that causes hard-to-treat infections in hospitals. Researchers collected samples from over 2,100 healthy people, patients, and hospital environments in the Netherlands, Italy, and Indonesia. By analyzing the bacteria's DNA, they hope to identify transmission routes and develop a global plan to prevent further spread.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NOSOCOMIAL INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr Cipto Mangunkusumo General Hospital
Jakarta, Indonesia
-
Erasmus Medical Center
Rotterdam, South Holland, 3015 GD, Netherlands
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a globally-applicable surveillance strategy to guide actions against the spread of CRPA in hospitals and communities.
What could go wrong
This is an observational study, not a treatment trial. It provides insights but does not directly test any intervention or cure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.